EXP THER MED 润色咨询

Experimental and Therapeutic Medicine

出版年份:2010 年文章数:8422 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:4.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2023-04-17 Ddffffg 来自上海

    偏重的研究方向:基础
    经验分享:Word版proof,引文怎么插入啊

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2023-04-20 pinger3557219 来自广东省

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2020-02-27 1467c2d1m03暂无昵称

    惊现审稿人Dr. H 2020-02-14 发表::
    Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿
    Dr. H 2020-02-14 00:00:00 发表:
    Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿

    Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2022-10-18 ms5000001622730751

    偏重的研究方向:药理;中药复方
    经验分享:请问收网络药理加实验吗

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2022-08-29 ms5000001731462752

    审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2022-06-24 ajxa1546

    我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2022-01-17 ms7000001369968346

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:综合;基础
    经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2021-12-27 ms6000000264964247

    所有作者在文章接收之后都会接收到邮件吗?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2021-12-28 Mia

    同一杂志社不同期刊如何转投(transfer)?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2126420, encodeId=019f2126420f0, content=偏重的研究方向:基础<br>经验分享:Word版proof,引文怎么插入啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Mon Apr 17 06:41:27 CST 2023, time=2023-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127258, encodeId=988f212e2586d, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:缺点是慢。审稿还是认真。尤其是编辑,审稿人没有什么意见,最后editor 提的问题对文章提升很用用。还有就是接收以后还不断提问。。。。没有说的那么烂吧,编辑还是在努力帮助提高文章质量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Thu Apr 20 14:47:41 CST 2023, time=2023-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=585480, encodeId=b276585480af, content=惊现审稿人<span class="quote">Dr. H 2020-02-14 发表::<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span><span class="quote">Dr. H 2020-02-14 00:00:00 发表:<br>Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿</span>, beContent=Dr. H 2020-02-14 发表:: Spandidos几乎所有journal我都审过,都很水,而且从来不剧稿, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/03/0380108019204f323435b170194e7f28.jpg, createdBy=b43b5142498, createdName=1467c2d1m03暂无昵称, createdTime=Thu Feb 27 00:00:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094599, encodeId=7666209459987, content=偏重的研究方向:药理;中药复方<br>经验分享:请问收网络药理加实验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65c58189363, createdName=ms5000001622730751, createdTime=Tue Oct 18 22:49:30 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241863, encodeId=fa46124186383, content=审稿一般要多久啊,2个月了一点消息没有,这个杂志under review是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172f6389910, createdName=ms5000001731462752, createdTime=Mon Aug 29 16:47:19 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228389, encodeId=8570122838978, content=我1月份投稿的,速度倒挺快,就是现在卡到提供原始数据这块了,不理解编辑什么意思。先是让提供图片,提供了之后又说上传Word和Excel格式的,有提供过的能否给出建议?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a2f2005212, createdName=ajxa1546, createdTime=Fri Jun 24 10:49:01 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185185, encodeId=383e118518505, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:综合;基础<br>经验分享:版面费840英镑,不算便宜。审稿速度还比较快,后期修回基本上一个星期内给意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a745707985, createdName=ms7000001369968346, createdTime=Mon Jan 17 14:10:30 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103743, encodeId=96db1103e4329, content=所有作者在文章接收之后都会接收到邮件吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103744, encodeId=e9c81103e44db, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001246, encodeId=f6161001246b4, content=投这个出版社旗下期刊的人都是牛人,真牛😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=848b2275602, createdName=121b4779m71(暂无昵称), createdTime=Tue Jul 20 21:12:13 CST 2021, time=2021-07-20, status=1, ipAttribution=)]
    2021-07-20 121b4779m71(暂无昵称)

    投这个出版社旗下期刊的人都是牛人,真牛😀

    1

    展开1条回复
共500条页码: 6/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分